📰 Cell Gene News
Cell Gene News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Gene. Real-time updates on events, politics, business and more.
May 23, 2024
BCMA-CD19 compound CAR (cCAR) therapy was safe and well tolerated and achieved proof of concept of complete humoral reset delivering long-term medication-free remission - iCell's BCMA-CD19 cCAR
January 23, 2024
/PRNewswire/ -- DelveInsights CAR T-Cell Therapy Market Insights report includes a comprehensive understanding of current treatment practices, emerging CAR...
August 22, 2023
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Allogeneic Cell Therapy Market: Distribution by Type of Cell Therapy, Source of Cell, Target...
August 9, 2023
/PRNewswire/ -- The "Allogeneic Cell Therapy: Global Market Report 2023-2035" report has been added to ResearchAndMarkets.coms offering. The global allogeneic...
May 12, 2023
DUBLIN--(BUSINESS WIRE)--The "CAR T - Cell Therapy - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 250+ companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product...
February 27, 2023
This article discusses three key themes in 2023 that are likely to have an outsized impact on biotech companies as well as the notable longer-term...
December 12, 2022
/PRNewswire/ -- The "CAR-T Cell Therapy Market by Target Indications, Target Antigens, Key Players and Key Geographies - Global Forecast 2022-2035" report has...
August 8, 2022
/PRNewswire/ -- The "Natural Killer (NK) Cell Therapeutics Market - A Global and Regional Analysis: Focus on NK Cell Therapy Type, Indication, Country,...
December 20, 2021
/PRNewswire/ -- The "Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026" report has been added to...
June 4, 2021
Share this article Share this article ResearchAndMarkets.coms offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to easily recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as "living drugs." T-cells form the backbone of CAR-T cell therapy. T-cells are the workhorses of our immune sy...